NORTHWEST BIOTHERAPEUTICS INCNWBO

Market cap
$345.05M
P/E ratio
Dec 31,
2013
Dec 31,
2014
Dec 31,
2015
Dec 31,
2016
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Dec 31,
2024
Cash and cash equivalents181322602201015722
Prepaid expenses and other current assets001112362222
Total current assets191524812431617944
Property, plant and equipment, net040460000115131716
Right-of-use asset, net------545444
Indefinite-lived intangible asset-------11111
Goodwill-------11111
Other assets-00001111000
Total non-current assets044474548161723222423
TOTAL ASSETS19587153492593340312827
Accounts payable and accrued expenses----1316677111017
Accounts Payable And Accrued Liabilities Related Parties Current----55154744
Convertible notes, net------140042
Convertible notes at fair value----------1318
Notes payable, net-11-7762715414
Contingent payable derivative liability------7889910
Warrant liability-452854030203551078112
Investor advances-----0---300
Share payable---------100
Lease liabilities------000000
Total current liabilities206965768870413821341264568
Convertible Notes At Fair Value, Non Current-----------16
Notes Payable, Noncurrent---332792562012
Operating Lease, Liability, Noncurrent------555444
Contingent payment obligation----------55
Total non-current liabilities-2511392121330103037
Total liabilities2093757996725339616413675106
Series C Convertible Preferred Stock-----------16
Temporary Equity, Carrying Amount, Attributable to Parent9--------2319-
Preferred Stock, Value, Issued------------
Common Stock, Value, Issued000001111111
Additional paid-in capital3754866316877227767951,0091,0671,1651,2911,345
Stock subscription receivable-----0000000
Accumulated deficit------824-840-1,371-1,192-1,297-1,360-1,443
Accumulated other comprehensive income---02-111-10323
Total stockholders' deficit---------2319-
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' DEFICIT19587153492593340312827